Clinical Supply Regulations Webinar 
BioPharma Drive: Drug Pricing
JUNE 9, 2025
Originally designed to regulate blood sugar in type 2 diabetes, GLP-1 receptor agonists have evolved into groundbreaking treatments for obesity, cardiovascular disease and even neurodegenerative conditions.
BioPharma Drive: Drug Pricing
JUNE 5, 2025
AI is here The FDA has been under pressure to create clear regulations for AI in the pharma industry for a few years and released a draft guidance in January to show how the agency will assess the risk of AI models in drug development. Its new CEO has to figure out what’s next.
Expert insights. Personalized for you.
147 
Let's personalize your content